InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs,…
Daily Archives
December 18, 2025
-
-
Investing
Iris Secures Right to High-grade Tungsten Project, Montana USA and Update on Capital Raising
by adminIRIS Metals Limited (ASX: IR1, “IRIS” or “the Company”) is pleased to announce it has executed a binding Heads of Agreement (HOA) with Finley Mining Inc for the exclusive right…
